Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Financial Flexibility Index
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥39.97 Million (operating CF CN¥-23.58 Million minus capex CN¥63.55 Million) represents 0% of total liabilities (CN¥1.46 Billion). Check Zhejiang Jolly Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Jolly Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 300181 cash flow metrics.
Annual Financial Flexibility Index for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Jolly Pharmaceutical Co Ltd. Explore Zhejiang Jolly Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.48x | CN¥698.95 Million | CN¥411.80 Million | CN¥1.47 Billion | ▼ -0.5% |
| 2024 | 0.48x | CN¥559.94 Million | CN¥297.05 Million | CN¥1.17 Billion | ▼ -3.0% |
| 2023 | 0.49x | CN¥420.18 Million | CN¥288.46 Million | CN¥853.09 Million | ▼ -12.8% |
| 2022 | 0.56x | CN¥496.63 Million | CN¥318.59 Million | CN¥879.19 Million | ▲ +8.1% |
| 2021 | 0.52x | CN¥399.75 Million | CN¥251.80 Million | CN¥765.31 Million | ▲ +16.0% |
| 2020 | 0.45x | CN¥338.04 Million | CN¥279.69 Million | CN¥750.43 Million | ▲ +70.9% |
| 2019 | 0.26x | CN¥169.40 Million | CN¥128.94 Million | CN¥642.86 Million | ▼ -17.6% |
| 2018 | 0.32x | CN¥232.21 Million | CN¥78.28 Million | CN¥726.50 Million | ▲ +61.7% |
| 2017 | 0.20x | CN¥130.90 Million | CN¥6.51 Million | CN¥662.06 Million | ▼ -44.5% |
| 2016 | 0.36x | CN¥201.55 Million | CN¥58.30 Million | CN¥566.00 Million | ▲ +19.9% |
| 2015 | 0.30x | CN¥123.21 Million | CN¥97.13 Million | CN¥414.94 Million | ▲ +73.6% |
| 2014 | 0.17x | CN¥52.99 Million | CN¥13.70 Million | CN¥309.75 Million | ▼ -45.6% |
| 2013 | 0.31x | CN¥53.23 Million | CN¥29.50 Million | CN¥169.38 Million | ▼ -26.4% |
| 2012 | 0.43x | CN¥67.55 Million | CN¥30.51 Million | CN¥158.27 Million | ▼ -8.9% |
| 2011 | 0.47x | CN¥74.98 Million | CN¥13.65 Million | CN¥159.99 Million | ▼ -35.9% |
| 2010 | 0.73x | CN¥103.46 Million | CN¥64.78 Million | CN¥141.47 Million | ▲ +52.1% |
| 2009 | 0.48x | CN¥63.49 Million | CN¥43.89 Million | CN¥132.07 Million | ▲ +44.0% |
| 2008 | 0.33x | CN¥43.66 Million | CN¥31.16 Million | CN¥130.76 Million | ▲ +41.7% |
| 2007 | 0.24x | CN¥25.17 Million | CN¥16.05 Million | CN¥106.79 Million | — |